The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of 177Lu-DOTATATE in patients (pts) with advanced pancreatic neuroendocrine tumors (pNETs): Data from the NETTER-R international, retrospective registry.
 
Dominique Clement
No Relationships to Disclose
 
Shaunak Navalkissoor
Consulting or Advisory Role - Advanced Accelerator Applications
 
Rajaventhan Srirajaskanthan
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis
Speakers' Bureau - Advanced Accelerator Applications
Research Funding - Ipsen
 
Frédéric Courbon
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen
Speakers' Bureau - Advanced Accelerator Applications; Ipsen
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen
 
Lawrence Dierickx
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen; Novartis
(OPTIONAL) Uncompensated Relationships - Ipsen; Novartis
 
Amy Eccles
Research Funding - Advanced Accelerator Applications
 
Valerie Lewington
Honoraria - Advanced Accelerator Applications; Bayer; Ipsen
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Ipsen; Nordic Nanovector
Speakers' Bureau - Advanced Accelerator Applications; Bayer; Ipsen
Research Funding - Advanced Accelerator Applications (Inst)
 
Mercedes Mitjavila
Consulting or Advisory Role - Advanced Accelerator Applications
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Curium Pharma
 
Juan Carlos Percovich
Honoraria - Novartis/Ipsen; Novo Nordisk; Pfizer; Sanofi
 
Benoît Lequoy
Employment - Advanced Accelerator Applications
Stock and Other Ownership Interests - Novartis
 
Beilei He
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Ilya Folitar
Employment - Advanced Accelerator Applications
 
John Ramage
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis
Speakers' Bureau - Advanced Accelerator Applications; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications; Ipsen; Novartis
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen